Drug Shortage Report for INTRALIPID 20%

Last updated on 2021-10-22 History
Report ID 145481
Drug Identification Number 02065673
Brand name INTRALIPID 20%
Common or Proper name Intralipid 20% (Lipid injectable emulsion) 500 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SOYBEAN OIL
Strength(s) 20%
Dosage form(s) EMULSION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500 mL
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-09-07
Actual start date 2021-09-07
Estimated end date 2021-10-21
Actual end date 2021-10-21
Shortage status Resolved
Updated date 2021-10-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-10-22 English Compare
v6 2021-10-21 French Compare
v5 2021-10-21 English Compare
v4 2021-10-07 French Compare
v3 2021-10-07 English Compare
v2 2021-09-10 French Compare
v1 2021-09-10 English Compare

Showing 1 to 7 of 7